Workflow #3556
✓ CompletedType: Benzinga Article
Started: December 05, 2025 at 9:03:30 PM
Completed: December 05, 2025 at 9:03:32 PM
Completed in 2s
Triggered by: ingestion
Job Pipeline
clean_raw_article
✓ completed→
clean_markdown_article
✓ completed→
analyze_article
✓ completed→
link_article_to_stories
⊘ skipped→
analyze_sentiment
⊘ skippedclean_raw_article
✓ CompletedPending
clean_markdown_article
✓ CompletedPending
analyze_article
✓ CompletedPending
link_article_to_stories
⊘ SkippedSkipped
analyze_sentiment
⊘ SkippedSkipped
Workflow Context
title:Kymera Therapeutics To Announce Results From BroADen Phase 1b Clinical Trial Evaluating KT-621, Oral STAT6 Degrader, In Patients With Moderate To Severe AD On December 8
source:Benzinga
content:
article_id:5176 →
content_type:article